Solubility, metastable zone width measurement and crystal growth of the 1:1 benzoic acid/isonicotinamide cocrystal in solutions of variable stoichiometry

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 3779-3786

  Boyd, Sarah ^a   Back, Kevin ^a   Chadwick, Keith ^a,b   Davey, Roger J ^a   Seaton, Colin C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Cocrystals; Crystal engineering; Crystallization; Metastable zone width; Solubility; Ternary phase diagram; X ray diffractometry

Indexed keywords

ALCOHOL; BENZOIC ACID; ISONICOTINAMIDE;

ARTICLE; COOLING; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; STOICHIOMETRY; TEMPERATURE SENSITIVITY; TURBIDITY;

EID: 77956357343     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22184     Document Type: Article

References (31)

1. Almarsson O, Zaworotko MJ. 2004. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical cocrystals represent a new path to improved medicines? Chem Commun 17:1889-1896.
2. Stahly GP. 2007. Diversity in single- and multiple-component crystals. The search for and prevalence of polymorphs and cocrystals. Cryst Growth Des 7:1007-1026.
3. Caira MR. 2007. Sulfa drugs as model cocrystal formers. Mol Pharmaceutics 4:310-316.
4. Shand N, Zaworotko MJ. 2008. The role of cocrystals in pharmaceutical science. Drug Discovery Today 13:440-446.
5. Desiraju GR. 1995. Supramolecular synthons in crystal engineering - A new organic synthesis. Angew Chem Int Ed 34:2311-2327.
6. Aakeröy CB, Salmon DJ. 2005. CrystEngComm 7:439-448.
7. Skovsgaard S, Bond AD. 2009. Co-crystallisation of benzoic acid derivatives with N-containing bases in solution and by mechanical grinding: Stoichiometric variants, polymorphism and twinning. CrystEngComm 11:444-453.
8. Bhogala BR, Nangia A. 2008. Ternary and quaternary cocrystals of 1,3-cis,5-cis cyclohexanetricarboxylic acid and 4,4′-bipyridines. New J Chem 32:800-807. (Pubitemid 351668109)
9. Braga D, Palladino G, Polito M, Rubini K, Grepioni F, Chierotti MR, Gobetto R. 2008. Three polymorphic forms of the co-crystal 4, 4′-bipyridine/pimelic acid and their structural, thermal and spectroscopic characterization. Chem Eur J 14:10149-10159.
10. Berry DJ, Seaton CC, Clegg W, Harrington RW, Coles SJ, Horton PN, Hursthouse MB, Storey R, Jones W, Friscic T, Blagden N. 2008. Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients. Cryst Growth Des 8:1697-1712.
11. Braga D, Giaffreda SL, Grepioni F, Petterson A, Maini L, Curzi M, Polito M. 2006. Mechanochemical preparation of molecular and supramolecular organometallic materials and coordination networks. Dalton Trans 1249-1263.
12. Friscic T, Jones W. 2009. Recent advances in understanding the mechanism of cocrystal formation via grinding. Cryst Growth Des 9:1621-1637.
13. Rodriguez-Hornedo N, Nehm SJ, Seedeldt KF, Pagan-Torres Y, Falkiewicz CF. 2006. Reaction crystallization of pharmaceutical molecular complexes. Mol Pharm 3:362-367. (Pubitemid 44021442)
14. Chiarella CA, Davey RJ, Peterson ML. 2007. Making cocrystals - The utility of ternary phase diagrams. Cryst Growth Des 7:1223-1226.
15. Childs SL, Rodriguez-Hornedo N, Reddy LS, Jayasankar A, Maheshwari C, McCausland L, Shipplett R, Stahly BC. 2008. Screening Strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine. CrystEngComm 10:856-864.
16. Chadwick K, Davey RJ, Dent G, Pritchard RG, Hunter CA, Musumeci D. 2009. Cocrystallisation: A solution chemistry perspective and the case of benzophenone and diphenylamine. Cryst Growth Des 9:1990-1999.
17. Ter Horst JH, Deij MA, Cains PW. 2009. Discovering new cocrystals. Cryst Growth Des 9:1531-1537.
18. Seaton CC, Parkin A, Wilson CC, Blagden N. 2009. Controlling the formation of benzoic acid:isonicotinamide molecular complexes. Cryst Growth Des 9:47-56.
19. Chadwick K, Davey RJ, Sadiq G, Cross W, Pritchard RG. 2009. Cocrystallisation: A solution Chemistry Perspective and the Case of Benzophenone and Diphenylamine. CrystEngComm 11:412-414.
20. Ainouz A, Authelin J-R, Billot P, Lieberman H. 2009. Modeling and prediction of cocrystal phase diagrams. Int J Pharm 374:82-89.
21. Sheikh AY, Rahim SA, Hammond RB, Roberts KJ. 2009. Scalable solution cocrystallisation: Case of carbamazepinenicotinamide I. CrystEngComm 11:501-509.
22. Gagniere E, Mangin D, Puel F, Bebon C, Klein J-P, Monnier O, Garcia E. 2009. Cocrystal formation in Solution: In-situ solute concentration monitoring of the two components and kinetic pathways. Cryst Growth Des 9:3376-3383.
23. Guo K, Sadiq G, Seaton CC, Davey RJ, Yin Q. 2010. Co-crystallisation in the Caffeine/maleic acid system - Lessions from phase equilibria. Cryst Growth Des 10:268-273.
24. Aakeröy CB, Beatty AM, Helfrich BA. 2001. "Total synthesis" supramolecular style: Design and hydrogen-bond-directed assembly of ternary supermolecules. Angew Chem Int Ed 40:3240-3242.
25. Sangster J. 1999. Phase diagrams and thermodynamic properties of binary systems of drugs. J Phys Chem Ref Data 28:889-930.
26. Nehm SJ, Rodriguez-Spong B, Rodriguez-Hornedo N. 2006. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation. Cryst Growth Des 6:592-600.
27. Schartman RR. 2009. On the thermodynamics of cocrystal formation. Int J Pharm 365:77-80.
28. Holmback X, Rasmuson AC. 1999. Size and morphology of benzoic acid crystals produced by drowned-out crystallisation. J Cryst Growth 198:780-788. (Pubitemid 129305757)
29. Bravais A. 1913. Études crystallographiques. Paris: Gauthier-Villars. p. 1866.
30. Friedel G. 1907. Études Sur la loi de Bravais. Bull Soc Fr Miner 9: 326.
31. Donnay JDH, Harker D. 1937. A new law of crystal morphology extending the law of Bravais. Am Mineral 22: 463.